No Data
No Data
Twist Bioscience Is Maintained at Overweight by Barclays
Twist Bioscience Is Maintained at Overweight by Barclays
Express News | Twist Bioscience : Barclays Raises Target Price to $60 From $45
Barclays Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $60
Barclays analyst Luke Sergott maintains $Twist Bioscience(TWST.US)$ with a buy rating, and adjusts the target price from $45 to $60.According to TipRanks data, the analyst has a success rate of 40.5%
Here's Why We're Not At All Concerned With Twist Bioscience's (NASDAQ:TWST) Cash Burn Situation
Twist Bioscience Is Maintained at Buy by TD Cowen
Twist Bioscience Is Maintained at Buy by TD Cowen
TD Cowen Maintains Buy on Twist Bioscience, Raises Price Target to $65
TD Cowen analyst Steven Mah maintains Twist Bioscience with a Buy and raises the price target from $55 to $65.